Viewing Study NCT00208988



Ignite Creation Date: 2024-05-05 @ 11:59 AM
Last Modification Date: 2024-10-26 @ 9:18 AM
Study NCT ID: NCT00208988
Status: COMPLETED
Last Update Posted: 2005-09-21
First Post: 2005-09-13

Brief Title: A Randomized Controlled Trial to Promote Physician-Patient Discussion of Prostate Cancer Screening
Sponsor: Emory University
Organization: Emory University

Study Overview

Official Title: A Randomized Controlled Trial to Promote Physician-Patient Discussion of Prostate Cancer Screening
Status: COMPLETED
Status Verified Date: 2005-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Prostate cancer is the most common type of cancer among men It is also the second leading cause of cancer-related death among men Two screening tests are available to try to detect prostate cancer early - the digital rectal examination DRE and the prostate specific antigen PSA blood test Unfortunately physicians arent sure whether or not these two screening tests help save lives and theres a lot of controversy about how to use them Recently a major government committee the US Preventive Services Task Force recommended that physicians discuss the risks and potential benefits of prostate cancer screening with their patients and allow patients to make their own decision

Because of the controversies many physicians currently dont discuss prostate cancer with their patients The problem is that it takes time and effort to have these discussions and the information is complicated A lot of patients have trouble understanding it especially if they have a limited educational background or trouble reading When patients have difficulty obtaining understanding and acting on basic health information we say that they have low health literacy Other researchers have shown that patients with low health literacy dont know as much about cancer screening and are less likely to get screened for various cancers They also tend to be timid about discussing things with their doctor and often go along with what the doctor says rather than taking an active role in the decision making

In 2003 under IRB approval we conducted a study with 2 goals 1 to encourage patients to talk to their doctor about prostate cancer screening and 2 to learn more about the impact of low health literacy on these conversations To promote conversation we used two handouts given to patients in the waiting room before they saw the doctor The first was a patient education handout about prostate cancer screening written in very simple terms with useful illustrations The second was a handout that simply encouraged patients to talk to their doctor about prostate cancer Patients got one of the two handouts or a nutritional handout that served as a control After they saw their doctor a research assistant briefly interviewed the patient to find out whether or not prostate cancer screening was discussed We also measured the patients health literacy skills and asked a few other questions about their decision to get screened for prostate cancer
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None